Skip to main content

Javier Hernandez Losa

Institutions of which they are part

Main researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Javier Hernandez Losa

Institutions of which they are part

Main researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

Patologia molecular translacional

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Cleofé Romagosa Pérez-Portabell, Maria Rosa Somoza Lopez de Haro, Jordi Temprana Salvador, Teresa Moline Marimon, Jessica Camacho Soriano, Carmela Iglesias i Felip, Josep Castellví Vives, Elena Muro Blanc, Marta Cano Galietero, Elena Antima Martinez Saez, Javier Hernandez Losa, Marta Sese Faustino, Vicente Peg Camara, Irene Sansano Valero, Trond Aasen , Stefan Hummer
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 40000
Reference: 2021 SGR 01138
Duration: 01/01/2022 - 30/06/2025

Anatomia Patològica (GRC)

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Cleofé Romagosa Pérez-Portabell, Inés de Torres Ramirez, Angel García Jiménez, Josep Castellví Vives, Maria Teresa Salcedo Allende, Javier Hernandez Losa, Marta Sese Faustino, Vicente Peg Camara, Irene Sansano Valero, Stefania Landolfi , Trond Aasen
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 1131
Duration: 01/01/2014 - 31/12/2016

Red Temática de Investigación Cooperativa en Cáncer (RTICC)

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Cleofé Romagosa Pérez-Portabell, Maria Rosa Somoza Lopez de Haro, Meritxell Bellet Ezquerra, Cristina Saura Manich, Angel García Jiménez, Patricia Gómez Pardo, Red Temática de Investigación Cooperativa en Cáncer (RTICC), Teresa Moline Marimon, Josep Castellví Vives, Judith Balmaña Gelpí, Pere Barba Suñol, Eva Muñoz Couselo, Javier Hernandez Losa, Marta Sese Faustino, Vicente Peg Camara, Stefania Landolfi , Trond Aasen
Funding agency: Instituto de Salud Carlos III
Funding: 209700
Reference: RD12/0036/0057
Duration: 01/01/2013 - 30/06/2017

Validación de Aprataxina como biomarcador de respuesta a Irinotecan en pacientes con cáncer colorrectal (ERANET- TRANSCAN)

IP: -
Collaborators: Javier Hernandez Losa, Stefania Landolfi , Elena Andretta
Funding agency: Instituto de Salud Carlos III
Funding: 135883
Reference: PI12/03103 (TRANSCAN)
Duration: 01/01/2013 - 30/06/2017

Related news

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Related professionals

Aina Llenas Bladé

Aina Llenas Bladé

Research technician
Childhood Cancer and Blood Disorders
Read more
Luis Gerardo Alcala Gonzalez

Luis Gerardo Alcala Gonzalez

Main researcher
Physiology and Pathophysiology of the Digestive Tract
Read more
Maria Luz Uría Oficialdegui

Maria Luz Uría Oficialdegui

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Joaquin Ruiz Altarejos

Joaquin Ruiz Altarejos

Research technician
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.